These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11351502)

  • 1. Lumbar vertebral cancellous bone is capable of responding to PGE2 treatment by stimulating both modeling and remodeling-dependent bone gain in aged male rats.
    Zhou H; Ma YF; Yao W; Cui L; Setterberg R; Liang CT; Jee WS
    Calcif Tissue Int; 2001 Mar; 68(3):179-84. PubMed ID: 11351502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain.
    Cui L; Ma YF; Yao W; Zhou H; Setterberg RB; Liang TC; Jee WS
    J Bone Miner Metab; 2001; 19(1):29-37. PubMed ID: 11156470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
    Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
    Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous PGE2 leads to net bone loss while intermittent PGE2 leads to net bone gain in lumbar vertebral bodies of adult female rats.
    Tian XY; Zhang Q; Zhao R; Setterberg RB; Zeng QQ; Iturria SJ; Ma YF; Jee WS
    Bone; 2008 May; 42(5):914-20. PubMed ID: 18316259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of daily administration of prostaglandin E2 and its withdrawal on the lumbar vertebral bodies in male rats.
    Ke HZ; Jee WS
    Anat Rec; 1992 Oct; 234(2):172-82. PubMed ID: 1416104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
    Jee WS; Mori S; Li XJ; Chan S
    Bone; 1990; 11(4):253-66. PubMed ID: 2242291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trabecular and endocortical bone surfaces in the rat: modeling or remodeling?
    Erben RG
    Anat Rec; 1996 Sep; 246(1):39-46. PubMed ID: 8876822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats.
    Akamine T; Jee WS; Ke HZ; Li XJ; Lin BY
    Bone; 1992; 13(1):11-22. PubMed ID: 1581103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys.
    Boyce RW; Niu QT; Ominsky MS
    Bone; 2017 Aug; 101():77-87. PubMed ID: 28428078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of prostaglandin E2 on production of new cancellous bone in the axial skeleton of ovariectomized rats.
    Mori S; Jee WS; Li XJ; Chan S; Kimmel DB
    Bone; 1990; 11(2):103-13. PubMed ID: 2192750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats.
    Ma YF; Ke HZ; Jee WS
    Bone; 1994; 15(2):137-46. PubMed ID: 8086230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial loss of anabolic effect of prostaglandin E2 on bone after its withdrawal in rats.
    Ke HZ; Li XJ; Jee WS
    Bone; 1991; 12(3):173-83. PubMed ID: 1910959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
    Ito H; Ke HZ; Jee WS; Sakou T
    Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic effect of prostaglandin E2 in bone is not dependent on pituitary hormones in rats.
    Chen MM; Yeh JK; Aloia JF
    Calcif Tissue Int; 1998 Sep; 63(3):236-42. PubMed ID: 9701628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs.
    Li XJ; Jee WS; Li YL; Patterson-Buckendahl P
    Bone; 1990; 11(5):353-64. PubMed ID: 2252812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats.
    Lin CH; Jee WS; Ma YF; Setterberg RB
    Bone; 1995 Oct; 17(4 Suppl):255S-259S. PubMed ID: 8579925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
    Jee WS; Ke HZ; Li XJ
    Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M; Jee WS; Ke HZ; Tang LY; Ma YF; Liang XG; Setterberg RB
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats.
    Ortoft G; Andreassen TT; Oxlund H
    Bone; 2005 Jan; 36(1):123-33. PubMed ID: 15664010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.